MEMPHIS Pharmaceuticals and Chemical Industries has announced a substantial 164% increase in profits for the last fiscal year, as revealed by its financial indicators.
In a statement released today to the Egyptian Stock Exchange, the company reported profits of EGP 504.92 million for the fiscal year spanning July 2024 to June 2025. This marks a significant rise from the EGP 191.45 million earned in the previous fiscal year.
The company’s sales also saw a robust increase, reaching 1.5 billion pounds in the last fiscal year, compared to 871.9 million pounds in the preceding year.
For the period from July to March 2025, MEMPHIS Pharmaceuticals achieved a net profit of EGP 375.75 million, up from EGP 166.36 million during the same timeframe the previous year.
Additionally, the company’s revenues for the first nine months of the current fiscal year climbed to 1.09 billion pounds, a notable increase from 664.57 million pounds in the equivalent period last year.
